Moreover, in subjects with diabetes who were at high risk of cardiovascular events, treatment with GLP-1R agonists based on the structure of endogenous GLP-1, namely liraglutide, semaglutide, albiglutide, and dulaglutide, has demonstrated reductions in major adverse cardiovascular events (MACEs) that appear to be unrelated to the glycemic effects of these agents (1316)
Bunlardan biri, orforglipron ad verilen ilacn eitli lkelerde onaylanmas
Similarly, naturally occurring RNA modifications, particularly pseudouridine (), suppress TLR activation, explaining why endogenous and -modified RNA are largely non-immunostimulatory
Furthermore, high-quality RCTs with adequate sample sizes should be conducted to compare the outcomes of different antioxidants